efocipegtrutide
Generic: Efocipegtrutide
efocipegtrutide: 1 clinical trial tracked.
efocipegtrutide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about efocipegtrutide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Primary endpoint: pharmacodynamic (PD) effect of HM15211
InterventionalRandomizedquadruple215 enrolledStarted 2020-07Completion 2026-0750 sites · South Korea, United StatesHanmi Pharmaceutical Company Limited